Brugada syndrome update
- PMID: 39896197
- PMCID: PMC11782167
- DOI: 10.3389/fphys.2024.1520008
Brugada syndrome update
Abstract
Brugada syndrome (BrS), a genetic disorder affecting cardiac ion channels, predominantly manifests due to mutations that impair the function of the Nav1.5 sodium channel's α-subunit. This condition, identified by Josep and Pedro Brugada, is often marked by symptoms such as syncope and episodes of polymorphic ventricular tachycardia (PVT) or ventricular fibrillation (VF). These arrhythmias, if not managed promptly, can escalate to sudden cardiac death (SCD), notably in patients whose cardiac structure appears normal. Given this, the prompt recognition and stratification of individuals at elevated risk are critical. This review elaborates on the current insights into BrS, focusing on recent diagnostic techniques, risk assessment strategies, and therapeutic advancements. It also critically examines ongoing controversies in the field.
Keywords: Brugada syndrome; implantable cardioverter defibrillator; quinidine; radiofrequency ablation; right ventricular outflow tract.
Copyright © 2025 Xu, Wang, Wang and Xing.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Al-Khatib S. M., Stevenson W. G., Ackerman M. J., Bryant W. J., Callans D. J., Curtis A. B., et al. (2017). 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Heart rhythm. 15 (10), e73–e189. 10.1016/j.hrthm.2017.10.036 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
